fda compounding glp 1 Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the Adverse Event Reporting System GLP-1 Medications – FDA Guidance

Recalls & Warnings September 08, 2012 Medifast Settles False Advertising Suit On September 7, 2012, Jason Pharmaceuticals Inc., a wholly owned subsidiary of Medifast, agreed to pay a $3.7 million civil penalty and meet new compliance requirements as part of a settlement with the U.S

Metabolism Ignite, from a company called Veracity, includes green-coffee-bean extract, which was associated with a small uptick in GLP-1 in one study

Crocetin, a carotenoid from Gardenia jasminoides Ellis, protects against hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats

3 Future directions Looking ahead, the future of GLP-1 research appears promising